072020 — Choong Ang Vaccine Laboratory Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Choong Ang Vaccine Laboratory, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	36,318	40,914	39,299	41,868	45,593
Cost of Revenue
Gross Profit	16,846	19,033	18,795	21,534	21,312
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	32,287	36,373	35,016	34,894	39,834
Operating Profit	4,031	4,541	4,283	6,974	5,758
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,313	6,401	4,807	7,479	7,963
Provision for Income Taxes
Net Income After Taxes	3,164	7,602	4,044	5,998	6,850
Net Income Before Extraordinary Items
Net Income	3,164	7,602	4,044	5,998	6,850
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,164	7,602	4,044	5,998	6,850
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	402	717	415	635	710
Dividends per Share